Half-normal Saline in Idiopathic Left Ventricular Outflow Tract Arrhythmias Ablation - Trial NCT03502499
Access comprehensive clinical trial information for NCT03502499 through Pure Global AI's free database. This phase not specified trial is sponsored by Texas Cardiac Arrhythmia Research Foundation and is currently Suspended. The study focuses on Ventricular Arrythmia. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Texas Cardiac Arrhythmia Research Foundation
Timeline & Enrollment
N/A
May 16, 2018
Apr 01, 2022
Primary Outcome
total radiofrequency ablation time, and total procedure time,acute success,long-term success
Summary
The study evaluates the use of half-normal saline as an irrigant for open-irrigated catheters
 during left ventricular outflow tract ventricular arrhythmias ablation. By increasing the
 efficacy of radiofrequency energy-mediated lesion formation, half-normal saline has the
 potential to reduce procedural times and improved acute and long-term outcomes.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03502499
Non-Device Trial